Short interest for Medite Cancer Diagnostics gives investors a sense of the degree to which investors are betting on the decline of Medite Cancer Diagnostics's stock. Short interest data is updated every two weeks.

Medite Cancer Diagnostics Stock Short Interest Report | OTC:MDIT | Benzinga

MEDITE CANCER DIAGNOSTICS by Medite Cancer Diagnostics, Inc.

Medite Cancer Diagnostics

Overview

Insider Trades

Medite Cancer Diagnostics Inc is a US-based company that specializes in the marketing and selling of MEDITE core products (instruments and consumables), manufacturing, development of new solutions in histology and cytology, and marketing of molecular biomarkers. The company manufactures medical devices and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company operates through a single segment for cancer diagnostics instruments and consumables for histology and cytology laboratories. It offers a range of histology laboratory devices for processing tissue, from receiving the tissue in the laboratory to the final diagnosis.

Comments

Medite Cancer Diagnostics Short Interest Report

Medite Cancer Diagnostics Stock Short Interest Report | OTC:MDIT | Benzinga